SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience. - Wikidata - wikimedia - TriplyDB

SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience.

SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience.

http://www.wikidata.org/entity/Q37000899

about

Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice Motion management in gastrointestinal cancers A current perspective on stereotactic body radiation therapy for pancreatic cancer Definitive concurrent chemoradiotherapy in locally advanced pancreatic cancer Neoadjuvant strategies for pancreatic cancer Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma Modeling Combined Chemotherapy and Particle Therapy for Locally Advanced Pancreatic Cancer Update on the Management of Pancreatic Cancer in Older Adults.A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocol.Pancreatic cancer and SBRT: A new potential option?Use of implanted gold fiducial markers with MV-CBCT image-guided IMRT for pancreatic tumours.Simple diagrammatic approach to delineate duodenum on a radiotherapy planning CT scan.Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer : A toxicity review of simultaneous integrated protection (SIP) versus conventional SBRT.Can Stereotactic Body Radiation Therapy Be a Viable and Efficient Therapeutic Option for Unresectable Locally Advanced Pancreatic Adenocarcinoma? Results of a Phase 2 Study.Stereotactic body radiation therapy as a derivative of stereotactic radiosurgery: clinically independent but with enduring common themes.Stereotactic body radiotherapy for locally-advanced unresectable pancreatic cancer-patterns of care and overall survival.Locally Advanced Pancreatic Cancer: A Review of Local Ablative Therapies.Stereotactic Body Radiation Therapy in the Management of Upper GI Malignancies.Stereotactic Radiotherapy and Particle Therapy for Pancreatic Cancer.Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity Dose escalation for locally advanced pancreatic cancer: How high can we go?Current and emerging radiotherapy strategies for pancreatic adenocarcinoma: stereotactic, intensity modulated and particle radiotherapy

P2860

Q27015651-13603588-95B6-45E0-B133-3AEC11D633EB Q27024637-892A57B3-35DA-4346-91B1-9DA811FDE167 Q28077111-12F392A3-C933-4A9A-B5BD-069B1400336A Q33923018-94D981AB-D5D0-4BBD-BBCE-F59C0217A139 Q33948343-4CB5F45F-EE6B-4DB7-BDB2-580EB173D656 Q35202400-FFF86B64-B27D-4514-8D1F-18F5F3D7A6AF Q35820403-08F32A1F-F773-4BB9-AFB3-B33A54B114D6 Q36095529-695F0487-574D-4DED-BB6E-8269964EF557 Q36130588-0FEB5D1E-E0EF-45FF-97A0-9E2298DA01B1 Q36133787-76B52917-BD3E-4221-9407-2D6AB3186C0D Q38387491-DEA4399D-A503-43E5-A196-F513780519E1 Q38662952-2237180E-0231-4183-8065-250F03EFFCF9 Q39110839-D5EA29D2-DAB5-4FD4-84B7-60ED994A1B39 Q42364897-E5034545-54B5-436E-A7CD-B87AAF1C27CB Q42857993-95A358F9-F468-4B1D-8392-50377CDC4A35 Q47146583-C41F505C-0AB3-49E1-96F5-5C5734313FB9 Q48270496-39AE12A2-3E50-4A26-A948-FD6577B65D83 Q55162030-9165061E-2EA2-4431-8F4E-77F99AA014AD Q55284451-3CDB5856-47D4-438A-9072-3BFB62FB1223 Q57483818-2B3AA907-942C-4625-8AF8-E3D7C1064FC2 Q57811272-8D30FC2C-EDE1-4E7C-A865-A5CFBC7C5375 Q58119172-0A1397C8-D672-4C2C-ABAA-9734761113A8 Q58784454-98F040C2-1790-4B45-A3BC-2CF6375B391F

P2860

SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience.

http://www.wikidata.org/entity/Q37000899

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

SBRT in unresectable advanced ...... mono-institutional experience.

@en

SBRT in unresectable advanced ...... mono-institutional experience.

@nl

type

label

SBRT in unresectable advanced ...... mono-institutional experience.

@en

SBRT in unresectable advanced ...... mono-institutional experience.

@nl

prefLabel

SBRT in unresectable advanced ...... mono-institutional experience.

@en

SBRT in unresectable advanced ...... mono-institutional experience.

@nl

P1433

Q37000899-E0FBB948-D3F6-4BB4-BD8D-E213698FEBFF

P1476

Q37000899-6D0C804E-F4D9-4F9A-BBCB-21A98D3DB40E

P2093

Q37000899-02576184-F47D-453E-9B18-D6B9543DF8FF

Q37000899-314CE69B-ACCA-4A66-8497-4BB8F0EA92A0

Q37000899-3DCC6C05-B4A1-4DF5-B7A8-8B8D26C52F3D

Q37000899-8165D9DE-CAD4-49D3-8CDC-371D4A748A0E

Q37000899-90CD128E-E8E6-4FE3-BB4F-3FAB4A793114

Q37000899-B348220F-7AB5-427B-946A-660AC96821F3

Q37000899-FACF2B39-5137-42B4-9419-61CEA3653786

P2860

Q37000899-1668DE0C-37E3-4F68-9D88-67251C08CFFB

Q37000899-35D26F9C-1163-4B47-A8ED-61ED012C1CA0

Q37000899-4073CDCA-9D60-41C1-85C6-E82F584EC82B

Q37000899-434DE32A-E760-4946-9529-93C9AB80389D

Q37000899-485D4306-7F1F-4992-9011-7208156CC925

Q37000899-54341722-EDA5-4CAE-9E0A-A5809ADBB430

Q37000899-6F6C0DB4-F640-4069-947D-F865CD5F968D

Q37000899-7E1F29A1-A559-4295-9D11-FBDDDFA595C8

Q37000899-89A7434E-6D6E-4D94-9806-3BA1249CADBC

Q37000899-9B7C97CF-1669-4EA5-9373-5FCAB6DBBA00

P2888

Q37000899-F60456BA-FCAA-4A87-868F-02A8614D3875

P304

Q37000899-E2A11B63-F8A6-4EC2-A6C1-21929DDA7A27

P31

Q37000899-59B00076-B943-4840-940F-61A634006278

P356

Q37000899-EB995EFF-6235-44AD-96F7-641DFCC60182

P478

Q37000899-A9CE6224-28F8-4675-961A-BBC90E5CFAFD

P50

Q37000899-96F65ABE-511F-4542-AD9A-4F7F597AA280

Q37000899-AC28AA0C-4522-400F-BFF1-86A67CC9C271

Q37000899-B226B403-DCBB-40E7-A9CA-EDA271C2D114

Q37000899-BDEC5351-B552-42A0-B5FB-01262A65DA63

Q37000899-C3DF93F3-2F3B-46E7-9A37-1704C41F7220

Q37000899-D1647053-8FB2-4141-85C6-4A97815E2C9F

Q37000899-F1F9F103-8196-46EB-B4D3-7C873FDF8E66

P577

Q37000899-C709F714-BD83-4EEF-AC73-8EE3CE933DF9

P6179

Q37000899-60454D86-B0BB-46F1-B783-5DE0B54DED50

P698

Q37000899-A13B03ED-C5BB-470E-9FE0-470D81B94B86

P932

Q37000899-1FBA295B-50D9-4EB0-AC18-71A4C47230F1

P356

1748-717X-8-148

P1433

Radiation Oncology

P1476

SBRT in unresectable advanced ...... mono-institutional experience

@en

P2093

Alessandro Zerbi

http://www.w3.org/2001/XMLSchema#string

Angelo Tozzi

http://www.w3.org/2001/XMLSchema#string

Cristina Iftode

http://www.w3.org/2001/XMLSchema#string

Giacomo Reggiori

http://www.w3.org/2001/XMLSchema#string

Luca Cozzi

http://www.w3.org/2001/XMLSchema#string

Pierina Navarria

http://www.w3.org/2001/XMLSchema#string

Stefano Tomatis

http://www.w3.org/2001/XMLSchema#string

P2860

Review and uses of stereotactic body radiation therapy for oligometastases

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer

Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group.

Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).

Locally advanced pancreatic cancer.

Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal/pelvic lymph nodes: report of dosimetric and early clinical results in oligometastatic patients.

Stereotactic body radiation therapy in multiple organ sites.

Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer.

Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A review.

P2888

1748-717x-8-148

P304

148

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1748-717X-8-148

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Lorenza Rimassa

Marta Scorsetti

Antonella Fogliata

P577

2013-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1020588513

http://www.w3.org/2001/XMLSchema#string

P698

23799996

http://www.w3.org/2001/XMLSchema#string

P932

3707803

http://www.w3.org/2001/XMLSchema#string